1/37
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
total calcium
normal range from 8.5-10.5 mg/dL
measures calcium found in the extracellular fluid (ECF)
affected by hypoalbuminemia
this is because if albumin is low, there are fewer binding sites for calcium
this means that the concentration of calcium will decrease, since the protein-bound concentrations are decreased
however, the free calcium (the active form) usually remains the same, since the body regulates these concentrations tightly (via PTH and vitamin D)
this matters because patients with low albumin can “look” hypocalcemic, if you only measure this specific concentration, but their free calcium may be normal—so they don’t actually have symptoms of hypocalcemia
this is why doctors often calculate “correct” calcium for albumin, or directly measure the free concentrations in these cases
ionized calcium
refers to the free or ACTIVE form of calcium
normal range from 4.5-5.5 mg/dL
these concentrations are maintained by the body within a tight range (via PTH and vitamin D)
corrected calcium equation
measured total Ca2++ + 0.8(4 - serum albumin)
serum calcium in mg/dL
serum albumin in g/dL
we would only use this if the serum albumin is less than 4
avoid using in critically ill patients or in patients with severely low albumin → it would be more beneficial to measure the ionized calcium in that case
hypercalcemia
total serum calcium > 10.5 mg/dL
or, if the ionized calcium is over the normal range (4.5-5.5 mg/dL)
remember, the lab value emergencies surround CALCIUM levels!
not phosphate or PTH levels!
mechanisms of hypercalcemia
increased bone resorption
PTH senses low calcium levels and causes increased osteoclast and osteoblast activity in the bone, leading to the breakdown of bone by osteoclasts
increased tubular reabsorption in the kidneys
increased renal calcium reabsorption and decreased renal phosphorous reabsorption
increased GI tract absorption
increased renal activation of vitamin D3 (calcitriol) causes increased intestinal calcium and phosphorous absorption/mobilization into the bloodstream
underlying causes of hypercalcemia
cancers
hyperparathyroidism
medications
granulomatous diseases
endocrine diseases
others
medications that can cause drug-induced hypercalcemia
thiazides
lithium
vitamin D
calcium
vitamin A
aluminum/magnesium antacids
theophylline
tamoxifen
ganciclovir
presentation of mild-moderate hypercalcemia
Ca2++ < 13 mg/dL
may be asymptomatic, or may have symptoms of fatigue or weakness
presentation of acute hypercalcemia
often due to cancer
anorexia
N/V
constipation
polydipsia
polyuria
nocturia
presentation of hypercalcemia crisis
Ca2++ > 15 mg/dL
patient may be unarousable
AKI
coma
arrhythmia
death
presentation of chronic hypercalcemia
soft tissue calcification
hypercalciuria
interstitial nephrocalcinosis (calcium deposits within the kidney's interstitial tissue) leading to CKD
nephrolithiasis
increased calcium + increased phosphate + increased PTH = deposition
treatment for acute, asymptomatic hypercalcemia → serum calcium < 12 mg/dL
they should be observed, and reversible causes should be corrected
treatment for acute, asymptomatic hypercalcemia → serum calcium > 12 mg/dL
they should be administered:
saline rehydration
loop diuretic
calcitonin
corticosteroid
bisphosphonate
treatment for acute, symptomatic, life-threatening hypercalcemia → functioning kidneys
these patients may present with complications such as ECG changes, tetany, or pancreatitis
they should be administered:
saline rehydration
loop diuretic
hemodialysis (low calcium bath)
calcitonin
corticosteroid
we also want to treat these patients rapidly with volume expansion (with normal saline)
hypercalcemic patients are often dehydrated
IV saline helps with rehydration, as well as increasing renal perfusion and consequently increasing GFR so more calcium is filtered out into the urine
with loop diuretic + hydration in combination → we want to drop the calcium 2-3 mg/dL over 1-2 days
treatment for acute, symptomatic, life-threatening hypercalcemia → severe kidney insufficiency
these patients may present with complications such as EKG changes, neurological effects, tetany, or pancreatitis
they should be administered:
hemodialysis (low to no calcium bath)
calcitonin
glucocorticoid
we also want to treat these patients rapidly with volume expansion (with normal saline)
hypercalcemic patients are often dehydrated
IV saline helps with rehydration, as well as increasing renal perfusion and consequently increasing GFR so more calcium is filtered out into the urine
with loop diuretic + hydration in combination → we want to drop the calcium 2-3 mg/dL over 1-2 days
treatment for acute, symptomatic, NON-life-threatening hypercalcemia
these patients may present with symptoms such as muscle weakness, fatigue, cognitive dysfunction, or abdominal pain
they should be administered:
saline rehydration
loop diuretic
calcitonin
corticosteroid
bisphosphonate
secondary considerations for acute-onset hypercalcemia
parathyroidectomy
reducing tumor load
discontinue offending medications
volume expansion with normal saline
mechanistically works to increase natriuresis, as well as increasing urinary calcium excretion
in dehydration, kidneys reabsorb more sodium and water (and calcium tags along) → hydrating the pt can enhance calcium clearance as it follows Na+/water
may need to add electrolytes after initial hydration (especially if using a loop dieuretic):
potassium
magnesium
loop diuretics
options:
furosemide
torsemide
bumetanide
ethacrynic acid
MOA: blocks Ca2+ and Na+ reabsorption in the thick ascending limb, increasing urinary calcium excretion
caution: do not dehydrate the patient → this can actually cause increased calcium reabsorption in the proximal tubule
dehydration = decrease plasma volume = lower GFR = lower clearance of calcium
give IV saline to hydrate the pt to enhance calcium excretion
need to monitor fluid/hydration status, K+, and Mg++
calcitonin
an alternative option to saline
used for short-term
rapid onset (1-2 hours)
has an unpredictable degree of calcium reduction
MOA: inhibits bone resorption, decreases tubular reabsorption of Ca++, and increases urinary calcium excretion
SQ or IM route
ADRs: flushing, N/V, hypersensitivity (administer test dose), tachyphylaxis (effect wears off)
bisphosphonates
options:
pamidronate
etidronate
zoledronate
ibandronate
commonly used in hypercalcemia due to cancer
MOA: blocks bone resorption
prevents hydrolysis of hydroxyapatite crystal (provides hardness to the bone) by phosphatases
prevents osteoclast precursors from binding to bone
onset is somewhat slow → 2-7 days
may be given with calcitonin
dosed q2-3 weeks
generally given via IV route, but PO can be used for maintenance in some cases
monitor SCr
ADRs: fever
corticosteroids
options:
prednisone (and others)
slow-onset → 3-5 days
MOA: decreases (dietary) calcium absorption and prevents calcitonin tachyphylaxis
they decrease calcium absorption by antagonizing vitamin D in the gut, reducing the transcription of calcium transporter proteins → decreased calcium mobilization
miscellaneous drugs used to treat hypercalcemia
denosumab
gallium nitrate
mithramycin
cinacalcet
hypocalcemia
total calcium < 8.5 mg/dL
has a high prevalence in the ICU where patients have hypoalbuminemia
we would use the corrected calcium equation in this case
ionized calcium < 4.5 mg/dL
generally not a medical emergency in most cases
emergent treatment can be warranted if seizures or tetany occur
generally, PTH is elevated as well,
exceptions: hypoparathyroidism or hypomagnesemia
common causes of hypocalcemia
vitamin D deficiency
hypomagenesemia
hungry bone syndrome
hypoparathyroidism
medications
vitamin D deficiency
the active form is essential for absorption of Ca++ and phosphorus in the gut
can lead to chronic hypocalcemia
common causes of vitamin D deficiency
malnourished populations
gastrointestinal disease or surgery
CKD → inability to activate vitamin D (a metabolic function of the kidney)
hypomagnesemia
can lead to:
impaired PTH secretion → it is required for exocytosis of PTH from the parathyroid
PTH resistance in target organs
severe, symptomatic hypocalcemia → even if calcium is low, the parathyroid can’t respond properly when it is severely low
if present, patients will be unresponsive to calcium replacement → we must replenish this deficiency first!!
hungry bone syndrome
this phenomenon follows a parathyroidectomy or thyroidectomy
especially in CKD patients who’ve had very high levels of PTH for a very long time, and suddenly they get surgery as treatment
so PTH levels go from very high to very low relatively quickly
in patients with chronically high PTH, their bones are in a state where resorption >>> formation, so the bones are basically depleted of minerals
when PTH sudden drops, osteoblasts aggressively deposit calcium into the bone matrix to restore density
essentially, the bones “suck up” all the calcium it can find, because they were in a chronic “loss” state
this can lead to very acute hypocalcemia
treatment includes calcium replacement and frequent monitoring
monitor q6h x1-2 days post-surgery
drug-induced causes of hypocalcemia
furosemide
cinacalcet
oral phosphorus
denosumab
calcitonin
bisphosphonates
mithramycin
gallium nitrate
pentamidine
ketoconazole
fluoride
concentrated citrate
phenobarbital
phenytoin
medications causes hypomagnesemia
clinical presentation of hypocalcemia
varies based on acuity
neuromuscular
parasthenia around mouth, cramping, tenancy, laryngeal spasms
CNS
depression, anxiety, seizure, confusion, hallucination, memory loss
dermatologic
alopecia, changes in nails
cardiac
prolonged QT, CHF symptoms, arrhythmia, bradycardia, hypotension
physical exam findings
positive Chvostek’s sign → facial twitching while tapping facial nerve
positive Trousseau’s sign → carpal spasm when BP cuff inflated > SBP for 3 minutes
treatment of hypocalcemia → hypomagenesemia
magnesium replacement
treatment of hypocalcemia → hypoparathyroidism
IV and oral calcium
oral vitamin D
treatment of hypocalcemia → concurrent medications
decrease doses or change therapy, if possible
treatment of hypocalcemia → vitamin D deficiency
oral or IV vitamin D replacement
treatment of hypocalcemia → symptomatic, acute
IV calcium chloride or gluconate bolus over 10 minutes
evaluate patient response to IV calcium as well as signs and symptoms
evaluate 10-12 hours after IV therapy or sooner for severe hypocalcemia
evaluate serum calcium every 24-48 hours initially during therapy, and then 1-2 times weekly
if patient is still symptomatic with calcium < 8.6 or ionized calcium < 4.4 → rebolus IV
treatment of hypocalcemia → Asymptomatic, acute
consider IV calcium gluconate bolus at 1g/hour
evaluate patient response to IV calcium as well as signs and symptoms
evaluate 10-12 hours after IV therapy or sooner for severe hypocalcemia
evaluate serum calcium every 24-48 hours initially during therapy, and then 1-2 times weekly
if patient is still symptomatic with calcium < 8.6 or ionized calcium < 4.4 → rebolus IV or increase dose of oral product
treatment of hypocalcemia → Asymptomatic, chronic
oral calcium 1-3g/day